Versant Venture Management as of Dec. 31, 2021
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 10 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gritstone Oncology Common Stock (GRTS) | 24.5 | $46M | 3.6M | 12.86 | |
| CRISPR Therapeutics Common Shares (CRSP) | 20.2 | $38M | 499k | 75.78 | |
| Passage Bio Common Stock (PASG) | 16.8 | $32M | 5.0M | 6.35 | |
| Aligos Therapeutics Common Stock (ALGS) | 14.7 | $28M | 2.3M | 11.87 | |
| Akero Therapeutics Common Stock (AKRO) | 7.0 | $13M | 618k | 21.15 | |
| Crinetics Pharmaceuticals Common Stock (CRNX) | 6.2 | $12M | 410k | 28.41 | |
| Adverum Biotechnologies Common Stock | 4.8 | $8.9M | 5.1M | 1.76 | |
| Minerva Surgical Common Stock | 4.6 | $8.6M | 1.7M | 5.14 | |
| CymaBay Therapeutics Common Stock | 1.0 | $1.8M | 544k | 3.38 | |
| Clovis Oncology Common Stock | 0.1 | $276k | 102k | 2.71 |
